title: Making sorafenib irresistible: In vivo screening for mechanisms of therapy resistance in hepatocellular carcinoma hits on Mapk14.
authors: Center for Applied Medical Research (CIMA), Division of Hepatology, University of Navarra, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Investigaciones Sanitarias de Navarra (IDISNA), University Clinic Navarra, Instituto de Salud Carlos III, Navarra, Spain.
authors: Matias
authors: M
authors: Avila
authors: Carmen
authors: C
authors: Berasain
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D048308:Mitogen-Activated Protein Kinase 14 / Q000037:antagonists & inhibitors* / Q000235:genetics*; D009536:Niacinamide / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D048308:Mitogen-Activated Protein Kinase 14